Crossmark

Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-021-07869-7

Published Online: 2021-02-06

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chu, Guanghua

Liu, Xiangzhen

Yu, Weiguang

Chen, Meiji

Dong, Lingyun
License Information

Text and Data Mining valid from 2021-02-06

Version of Record valid from 2021-02-06
More Information

Article History

Received: 8 October 2020

Accepted: 2 February 2021

First Online: 6 February 2021

Ethics approval and consent to participate

: This study was approved by the Medical Ethics Committee (The First Affiliated Hospital, Sun Yat-sen University), and an exemption from informed consent was obtained from our responsible Investigational Review Board.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below